𝔖 Bobbio Scriptorium

✦ LIBER ✦

Recombinant pox virus containing human cytomegalovirus DNA; expression in vaccinia virus and avipox virus vector, for application as a recombinant vaccine : Virogenetics World 9639 491; 12 December 1996

Book ID: 117432816
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 229 KB
Volume: 15
Category: Article
ISSN: 0264-410X
DOI: 10.1016/s0264-410x(97)87011-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant poxvirus containing Plasmodi

Recombinant poxvirus containing Plasmodium DNA in nonessential region; Plasmodium falciparum gene cloning using a vaccine or canary-pox virus vector for use as a malaria recombinat vaccine : Virogenetics World 9428 930; 22 December 1994

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 143 KB

New viral DNA molecules and polypeptides

New viral DNA molecules and polypeptides; herpes simplex virus-1 and cytomegalovirus recombinant protein production by gene expression in Escherichia coli, for application as a recombinant vaccine against atherosclerosis : Bio-Virus Research USA 5534 258; 9 July 1996

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Flea serine protease and flea aminopepti

Flea serine protease and flea aminopeptidase DNA and protein; recombinant enzyme production by vector expression in host cell, and virus, for application as a recombinant vaccine against e.g. Ctenocephalides felis and Pulex irritans: Heska World 9611 706; 25 April 1996

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 181 KB

PDK-53, a clone of infectious attenuated

PDK-53, a clone of infectious attenuated Dengue-2 virus strain 16681; Dengue virus-2 cloning and vector expression in host cell, for application as a live, attenuated, quadravalent recombinant vaccine : U.S. Dept. Health Hum. Serv. Rockville Univ. Mahidal-Salaya World 9640 933; 19 December 1996

📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Enhancing immunogenicity by coupling imm

Enhancing immunogenicity by coupling immunogen to serum albumin binding protein; virus recombinant immunogen and serum albumin binding fusion protein production by vector expression in e.g. Escherichia coli, by surface display, for application as a recombinant vaccine : Pierre-Fabre Med. World 9614 416; 17 May 1996

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 181 KB